Search

Your search keyword '"T cells -- Health aspects"' showing total 6,943 results
Start Over Descriptor "T cells -- Health aspects"
6,943 results on '"T cells -- Health aspects"'

151. New study offers hope for a rare and devastating eye cancer

Author

Johnson, Mark

Subjects
Oncology, Experimental, T cells -- Health aspects, Eye cancer -- Physiological aspects -- Care and treatment, Cellular therapy -- Research, Cancer -- Care and treatment -- Research, General interest, News, opinion and commentary
Abstract

Byline: Mark Johnson After more than a decade studying a rare eye cancer that produces some of the hardest-to-fight tumors, researchers from University of Pittsburgh Medical Center have found a [...]

Published
2024

154. Challenges of Expanding CAR-T Cell Therapy into Solid Tumors: The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges

Author

Huber, Brian and Joeckel, Tamie

Subjects
T cells -- Health aspects, Tumors -- Care and treatment -- Patient outcomes, Cancer -- Care and treatment, Biotechnology industry, Business, Pharmaceuticals and cosmetics industries
Abstract

Since the first FDA approval in 2017, chimeric antigen receptor T-cell (CAR-T) therapy has garnered excitement as a potentially curative option for hard-to-treat blood cancers (1). In this therapy, T [...]

Published
2023

155. Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors

Author

Bonifacius, Agnes, Lamottke, Britta, Tischer-Zimmermann, Sabine, Schultze- Florey, Rebecca, Goudeva, Lilia, Heuft, Hans-Gert, Arseniev, Lubomir, Beier, Rita, Beutel, Gernot, Cario, Gunnar, Frohlich, Birgit, Greil, Johann, Hansmann, Leo, Hasenkamp, Justin, Hofs, Michaela, Hundsdoerfer, Patrick, Jost, Edgar, Kafa, Kinan, Kriege, Oliver, Kroger, Nicolaus, Mathas, Stephan, Meisel, Roland, Nathrath, Michaela, Putkonen, Mervi, Ravens, Sarina, Reinhardt, Hans Christian, Sala, Elisa, Sauer, Martin G., Schmitt, Clemens, Schroers, Roland, Steckel, Nina Kristin, Trappe, Ralf Ulrich, Verbeek, Mareike, Wolff, Daniel, Blasczyk, Rainer, Eiz-Vesper, Britta, and Maecker-Kolhoff, Britta

Subjects
Cells -- Transplantation, Epstein-Barr virus diseases -- Complications and side effects, T cells -- Health aspects, Immunotherapy -- Methods, Lymphoproliferative disorders -- Care and treatment, Graft versus host reaction -- Care and treatment, Health care industry
Abstract

BACKGROUND. Adoptive transfer of EBV-specific T cells can restore specific immunity in immunocompromised patients with EBV-associated complications. METHODS. We provide results of a personalized T cell manufacturing program evaluating donor, patient, T cell product, and outcome data. Patient-tailored clinical-grade EBV-specific cytotoxic T lymphocyte (EBV-CTL) products from stem cell donors (SCDs), related third-party donors (TPDs), or unrelated TPDs from the allogeneic T cell donor registry (alloCELL) at Hannover Medical School were manufactured by immunomagnetic selection using a CliniMACS Plus or Prodigy device and the EBV PepTivators EBNA-1 and Select. Consecutive manufacturing processes were evaluated, and patient outcome and side effects were retrieved by retrospective chart analysis. RESULTS. Forty clinical-grade EBV-CTL products from SCDs, related TPDs, or unrelated TPDs were generated for 37 patients with refractory EBV infections or EBV-associated malignancies with and without a history of transplantation, within 5 days (median) after donor identification. Thirty-four patients received 1-14 EBV-CTL products (fresh and cryopreserved). EBV-CTL transfer led to a complete response in 20 of 29 patients who were evaluated for clinical response. No infusion-related toxicity was reported. EBV-specific T cells in patients' blood were detectable in 16 of 18 monitored patients (89%) after transfer, and their presence correlated with clinical response. CONCLUSION. Personalized clinical-grade manufacture of EBV-CTL products via immunomagnetic selection from SCDs, related TPDs, or unrelated TPDs in a timely manner is feasible. Overall, EBV-CTLs were clinically effective and well tolerated. Our data suggest EBV-CTL transfer as a promising therapeutic approach for immunocompromised patients with refractory EBV-associated diseases beyond HSCT, as well as patients with preexisting organ dysfunction. TRIAL REGISTRATION. Not applicable. FUNDING. This study was funded in part by the German Research Foundation (DFG, 158989968/SFB 900), the Deutsche Kinderkrebsstiftung (DKS 2013.09), Wilhelm-Sander-Stiftung (reference 2015.097.1), Ellen-Schmidt-Program of Hannover Medical School, and German Federal Ministry of Education and Research (reference 01E00802)., Introduction Morbidity and mortality in patients with hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) are frequently caused by graft rejection or graft-versus-host disease (GvHD) and increased by [...]

Published
2023
Full Text
View/download PDF

156. Concerns about a revolutionary cancer therapy

Subjects
United States. Food and Drug Administration, T cells -- Health aspects, Antineoplastic agents -- Health aspects, Immunotherapy -- Health aspects, B cells -- Health aspects, Cancer -- Care and treatment, Antimitotic agents -- Health aspects
Abstract

CAR-T cell therapy is a type of cancer immunotherapy often offered to patients when other treatments have not worked. However, the US Food and Drug Administration is investigating reports that [...]

Published
2023

157. DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cells

Subjects
T cells -- Health aspects, DNA -- Health aspects, Methylation -- Health aspects, Cell differentiation -- Health aspects, Epigenetic inheritance -- Health aspects, Physical fitness -- Health aspects, Virus diseases -- Health aspects, Health
Abstract

2023 NOV 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2023

158. New Lentivirus Study Results Reported from Mayo Clinic (Translational Development of a Novel Baff-r Car-t Therapy Targeting B-cell Lymphoid Malignancies)

Subjects
T cells -- Health aspects, Non-Hodgkin's lymphomas -- Health aspects, Cancer -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2023 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on RNA Viruses - Lentivirus have been published. According [...]

Published
2023

159. Impact of Memory T Cells on SARS-COV-2 Vaccine Response in Hematopoietic Stem Cell Transplant

Subjects
Vaccination -- Health aspects, T cells -- Health aspects, Stem cells -- Health aspects, Hematopoietic stem cells -- Transplantation, RNA -- Health aspects, Stem cell research -- Health aspects, Health
Abstract

2023 NOV 13 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2023

160. Reports on Cytomegalovirus from University Hospital 12 Octubre Provide New Insights (Dynamics and Clinical Significance of Cytomegalovirus-specific Neutralizing Antibodies In Kidney Transplant Recipients Treated With T-cell-depleting Agents)

Subjects
Kidneys -- Transplantation, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, T cells -- Health aspects, Viral antibodies -- Health aspects, Antithymocyte globulin -- Health aspects, Cytomegalovirus infections -- Health aspects, Antibodies -- Health aspects, Physical fitness -- Health aspects, Organ transplant recipients -- Health aspects, Health
Abstract

2023 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Herpesvirus Diseases and Conditions - Cytomegalovirus. According [...]

Published
2023

162. Study Results from Emory University Update Understanding of Obesity, Fitness and Wellness (Callus γδt Cells and Microbe-induced Intestinal Th17 Cells Improve Fracture Healing In Mice)

Subjects
United States. National Institutes of Health, T cells -- Health aspects, Fractures -- Health aspects, Physical fitness -- Health aspects, Medical laboratories -- Health aspects, Health, Emory University
Abstract

2023 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Obesity, Fitness and Wellness are discussed in a new [...]

Published
2023

163. Atara Biotherapeutics expands global tab-cel partnership with Pierre Fabre Laboratories

Subjects
T cells -- Health aspects, International cooperation -- Health aspects, Immunotherapy -- Health aspects, Pharmaceuticals and cosmetics industries
Abstract

Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, reported recent [...]

Published
2023

164. Kite and Epic Bio announce collaboration to develop new therapies for cancer

Subjects
T cells -- Health aspects, Cancer -- Health aspects, Company licensing agreement, Business, News, opinion and commentary
Abstract

Kite, a Gilead company and Epicrispr Biotechnologies or Epic Bio announced the companies have entered into a research collaboration and license agreement using Epic Bio's proprietary gene regulation platform to [...]

Published
2023

165. Virion Therapeutics, Ocean Biomedical begin patient dosing in phase 1b trial of VRON-0200 immunotherapy for chronic HBV infection

Subjects
T cells -- Health aspects, Immunotherapy -- Health aspects, Infection -- Health aspects, Hepatitis B -- Health aspects, Clinical trials -- Health aspects, Venture capital companies -- Joint ventures -- Product development, Company joint venture, Pharmaceuticals and cosmetics industries
Abstract

Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies, and its Joint Venture partner, Ocean Biomedical, Inc., announced that the first patients have been dosed in the [...]

Published
2023

166. Kyushu University Researchers Broaden Understanding of Multiple Sclerosis (Iguratimod Ameliorates the Severity of Secondary Progressive Multiple Sclerosis in Model Mice by Directly Inhibiting IL-6 Production and Th17 Cell Migration via ...)

Subjects
Interleukin-6 -- Health aspects, T cells -- Health aspects, Multiple sclerosis -- Drug therapy -- Models, Inflammation -- Drug therapy, Cell migration -- Research, Antirheumatic agents -- Research, Neuroglia -- Health aspects, Pharmaceutical research, Health
Abstract

2023 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on multiple sclerosis. According to news reporting originating [...]

Published
2023

167. Differential and lasting gene expression changes in circulating CD8 T cells in chronic HCV infection with cirrhosis and related insights on the role of Hedgehog signaling

Subjects
Gene expression -- Health aspects, T cells -- Health aspects, RNA sequencing -- Health aspects, Genes -- Health aspects, Hepatitis C virus -- Health aspects, Infection -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2023 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2023

168. New Findings from University of Fribourg Describe Advances in Retinal Degeneration (Assessing the role of T cells in response to retinal injury to uncover new therapeutic targets for the treatment of retinal degeneration)

Subjects
Retinal degeneration -- Care and treatment -- Development and progression, T cells -- Health aspects, Immune response -- Research, Cell interaction -- Research, Health
Abstract

2023 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in retinal degeneration. According to news originating from [...]

Published
2023

169. Wuhan University Researchers Add New Study Findings to Research in Pharmacology (CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis)

Subjects
Cholesterol -- Health aspects, T cells -- Health aspects, Biosynthesis -- Methods, Acute lymphocytic leukemia -- Development and progression, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in pharmacology. According to news reporting out of [...]

Published
2023

170. Sichuan Cancer Hospital & Institute Researcher Yields New Findings on Squamous Cell Carcinoma (343. T Lymphocyte Subsets Characteristics in Different Curative Efficacy of Neoadjuvant Therapy For Patients With Esophageal Squamous Cell Carcinoma)

Subjects
T cells -- Health aspects, Neoadjuvant therapy -- Methods, Squamous cell carcinoma -- Care and treatment, Esophageal cancer -- Care and treatment, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on squamous cell carcinoma is now available. According to [...]

Published
2023

171. New Data from Charite University Hospital and School of Medicine Illuminate Findings in Gene Editing (Car Nk-92 Cell-mediated Depletion of Residual Tcr Plus Cells for Ultrapure Allogeneic Tcr-deleted Car T-cell Products)

Subjects
T cells -- Health aspects, Graft versus host reaction -- Development and progression -- Care and treatment, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Biotechnology - Gene Editing is now available. According [...]

Published
2023

172. Direct Antigen Presentation is the Canonical Pathway of Cytomegalovirus CD8 T-cell Priming Regulated by Balanced Immune Evasion Mounting a Strong Antiviral Response

Subjects
T cells -- Health aspects, Antigens -- Health aspects, Cytomegalovirus infections -- Health aspects, Physical fitness -- Health aspects, Viral proteins -- Health aspects, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2023

173. Data from Roswell Park Cancer Institute Update Knowledge in Non-Small Cell Lung Cancer (Location of CD39+ T cell subpopulations within tumors predict differential outcomes in non-small cell lung cancer)

Subjects
T cells -- Health aspects, Lung cancer, Non-small cell -- Development and progression -- Patient outcomes, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in non-small cell lung cancer. According to news [...]

Published
2023

174. Researchers from Massachusetts General Hospital Detail New Studies and Findings in the Area of Cell Therapy (Automated Detection of Immune Effector Cell-associated Neurotoxicity Syndrome Via Quantitative Eeg)

Subjects
T cells -- Health aspects, Cellular therapy -- Patient outcomes, Neurotoxicity syndromes -- Diagnosis -- Care and treatment, Electroencephalography -- Methods, Health
Abstract

2023 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Cell Therapy have been [...]

Published
2023

175. Research Reports on Lymphocytic Choriomeningitis Virus from Emory University School of Medicine Provide New Insights (PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into ...)

Subjects
T cells -- Health aspects, Immune response -- Analysis, Immunotherapy -- Patient outcomes, Health
Abstract

2023 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on lymphocytic choriomeningitis virus have been published. According to [...]

Published
2023

176. Recent Findings from Nanjing Medical University Highlight Research in Immunoconjugates (Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH)

Subjects
Antibody-toxin conjugates -- Health aspects, T cells -- Health aspects, Viral antibodies -- Health aspects, Hydrogen-ion concentration -- Health aspects, Cancer cells -- Health aspects, Antibodies -- Health aspects, Health
Abstract

2023 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on immunoconjugates have been presented. According to news reporting originating [...]

Published
2023

177. Chinese Academy of Medical Sciences Researcher Updates Understanding of Age-Related Macular Degeneration (Identification of the Immune Landscapes and Follicular Helper T Cell-Related Genes for the Diagnosis of Age-Related Macular Degeneration)

Subjects
T cells -- Health aspects, Macular degeneration -- Diagnosis -- Genetic aspects, DNA testing, Health
Abstract

2023 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on age-related macular degeneration. According to news reporting [...]

Published
2023

178. Research Conducted at Koch Institute for Integrative Cancer Research Has Provided New Information about Solid Cancer (Universal Redirection of Car T Cells Against Solid Tumours Via Membrane-inserted Ligands for the Car)

Subjects
Fluorescein -- Usage, T cells -- Health aspects, Tumors -- Care and treatment, Ligands (Biochemistry) -- Usage -- Health aspects, Dyes and dyeing -- Usage, Therapeutics, Experimental, Molecular targeted therapy -- Research, Health
Abstract

2023 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Solid Cancer have been presented. According to [...]

Published
2023

179. Relapsed or Refractory Diffuse Large B-Cell Lymphoma: 'Dazed and Confused'

Author

Kesireddy, Meghana and Lunning, Matthew A.

Subjects
T cells -- Health aspects, Mortality, Stem cells -- Health aspects, Non-Hodgkin's lymphomas -- Care and treatment, Drug approval -- Health aspects, Chemotherapy -- Health aspects, Cancer -- Chemotherapy, Health
Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Approximately 30% to 40% of patients will develop relapsed/refractory (R/R) DLBCL, leading to signifi cant morbidity and mortality. Salvage chemoimmunotherapy followed by high-dose chemotherapy and autologous stem cell rescue (HDT-ASCR) is the standard of care for chemosensitive and transplant-eligible R/R DLBCL. In patients who are ineligible for HDT-ASCR or who fail HDT-ASCR, treatment is mostly with palliative intent. However, the recent advances with chimeric antigen receptor T-cell (CAR-T) therapy and several FDA-approved targeted agents are changing the current landscape of R/R DLBCL management. There is no one-size-fi ts-all approach, and guidance regarding optimal sequencing of subsequent therapies is an unmet need. This review highlights the approved CAR-T constructs, including their effi cacy, adverse effects, and real-world data; bridging therapy to CAR-T; the role of emerging targeted agents, including bispecifi c antibodies; and the timing of these targeted agents in relation to CAR-T therapy. Providing individualized treatment with thoughtful sequencing of available agents is essential until future prospective randomized clinical trials provide more insights., Introduction Diffuse large B-cell lymphoma (DL-BCL) is the most common subtype of non-Hodgkin lymphoma (NHL) and accounts for 30% to 40% of all NHL cases. The median age at diagnosis [...]

Published
2022

180. Data on Cancer Detailed by Researchers at University of Pennsylvania (Enhancing Cellular Immunotherapies In Cancer By Engineering Selective Therapeutic Resistance)

Subjects
Oncology, Experimental -- Health aspects, T cells -- Health aspects, Immunotherapy -- Health aspects, Genetic engineering -- Health aspects, Cancer -- Drug therapy -- Research, Business, Health, Health care industry, University of Pennsylvania
Abstract

2024 AUG 20 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Cancer is now available. According to news reporting out of Philadelphia, [...]

Published
2024

182. Immunological presentations and clinical features associated with Thymic Malignancies: The potential role of histological classifications and tumour grading on the future recurrence of opportunistic infections and paraneoplastic autoimmune conditions

Subjects
T cells -- Health aspects, Diseases -- Relapse, Cancer -- Health aspects, Health
Abstract

2024 AUG 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

184. CD6 Regulates CD4 T Follicular Helper Cell Differentiation and Humoral Immunity During Murine Coronavirus Infection

Subjects
Coronavirus infections -- Health aspects, T cells -- Health aspects, Infection -- Health aspects, Cell differentiation -- Health aspects, Coronaviruses -- Health aspects, Health
Abstract

2024 AUG 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

185. Researchers from Feinstein Institute for Medical Research Report Findings in COVID-19 (Factors Associated With Immune Responses To Sars-cov-2 Vaccination In Individuals With Autoimmune Diseases)

Subjects
United States. National Institute of Allergy and Infectious Diseases, Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Communicable diseases -- Care and treatment -- Risk factors, T cells -- Health aspects, Autoimmunity -- Health aspects, Immune response -- Health aspects, Belimumab -- Health aspects, Coronaviruses -- Health aspects, Autoimmune diseases -- Risk factors -- Care and treatment, Health
Abstract

2024 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on Coronavirus - COVID-19. According to news reporting out of Manhasset, [...]

Published
2024

187. SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation

Subjects
T cells -- Health aspects, Tumors -- Health aspects, Antigenic determinants -- Health aspects, Dendritic cells -- Health aspects, Tumor antigens -- Health aspects, Cancer vaccines -- Health aspects, Health, Health aspects
Abstract

2024 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

189. New Findings in COVID-19 Described from La Jolla Institute for Immunology (Sars-cov-2 Breakthrough Infections Enhance T Cell Response Magnitude, Breadth, and Epitope Repertoire)

Subjects
United States. National Institutes of Health, United States. National Institute of Allergy and Infectious Diseases, Cell Press, T cells -- Health aspects, Antigenic determinants -- Health aspects, Severe acute respiratory syndrome -- Health aspects, Periodical publishing -- Health aspects, Coronaviruses -- Health aspects, Business, Health, Health care industry
Abstract

2024 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- A new study on Coronavirus - COVID-19 is now available. [...]

Published
2024

190. New Findings from National Institute of Allergy and Infectious Diseases (NIAID) in the Area of COVID-19 Reported (Il-10 Suppresses T Cell Expansion While Promoting Tissue-resident Memory Cell Formation During Sars-cov-2 Infection In Rhesus ...)

Subjects
United States. National Institute of Allergy and Infectious Diseases, Memory (Computers) -- Health aspects, Communicable diseases -- Health aspects, T cells -- Health aspects, Infection -- Health aspects, Coronaviruses -- Health aspects, Semiconductor memory, Business, Health, Health care industry, Public Library of Science
Abstract

2024 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Data detailed on Coronavirus - COVID-19 have been presented. According [...]

Published
2024

192. Report Summarizes HIV/AIDS Study Findings from Western University of Health Sciences (Dysregulation of Gamma Delta T-cells, Cd8+t Cells, Cd4+t Cells, and Natural Killer Cells In Brain Pathology: Understanding Hiv-induced Impairment and ...)

Subjects
HIV (Viruses) -- Health aspects, Brain -- Health aspects, T cells -- Health aspects, Nervous system diseases -- Health aspects, Killer cells -- Health aspects, Health
Abstract

2024 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Fresh data on Immune System Diseases and Conditions - HIV/AIDS are presented in a new [...]

Published
2024

194. Investigators from University of Jinan Release New Data on Personalized Medicine (Harnessing Cd8+ T Cell Dynamics In Hepatitis B Virus-associated Liver Diseases: Insights, Therapies and Future Directions)

Subjects
T cells -- Health aspects, Infection -- Development and progression, Hepatitis B -- Development and progression, Hepatitis B virus -- Development and progression, Health
Abstract

2024 JUL 26 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Drugs and Therapies - Personalized Medicine are discussed in a [...]

Published
2024

196. Data from Thomas Jefferson University Advance Knowledge in COVID-19 (Mrna-lnp Vaccine-induced Cd8+t Cells Protect Mice From Lethal Sars-cov-2 Infection In the Absence of Specific Antibodies)

Subjects
T cells -- Health aspects, Messenger RNA -- Health aspects, Infection -- Health aspects, Vaccines -- Health aspects, Coronaviruses -- Health aspects, Business, Health, Health care industry, Thomas Jefferson University
Abstract

2024 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Researchers detail new data in Coronavirus - COVID-19. According to [...]

Published
2024

197. The Ex Vivo Infection of the Peripheral Bovine Mononuclear Cells (PBMCs) and the Bovine Spleen Cells with the Bovine Coronavirus (BCoV) Induced a Differential Expression of the Host Cytokine Genes Profiles and Modulates the Virus Replication

Subjects
Cytokines -- Health aspects, T cells -- Health aspects, Genes -- Health aspects, Infection -- Health aspects, Coronaviruses -- Health aspects, Biological sciences, Health
Abstract

2024 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2024

198. New Human T-Lymphotropic Virus 1 Study Results Reported from University of Pittsburgh (Nf-kb1 Deficiency Promotes Macrophage-derived Adrenal Tumors but Decreases Neurofibromas In Htlv-i Ltr-tax Transgenic Mice)

Subjects
T cells -- Health aspects, Genetic engineering -- Health aspects, Macrophages -- Health aspects, Health, Public Library of Science, University of Pittsburgh
Abstract

2024 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Current study results on Immune System Diseases and Conditions - Human T-Lymphotropic Virus 1 have [...]

Published
2024

199. Findings from Wenzhou Medical University in the Area of Cancer Reported (Enzyme-instructed Photoactivatable Supramolecular Antigens On Cancer Cell Membranes for Precision-controlled T-cell-based Cancer Immunotherapy)

Subjects
T cells -- Health aspects, Immunotherapy -- Health aspects, Antigens -- Health aspects, Cancer -- Care and treatment -- Drug therapy, Enzymes -- Health aspects, Cell membranes -- Health aspects, Health
Abstract

2024 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on Cancer are presented in a new report. According to news reporting originating [...]

Published
2024

200. Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy

Subjects
Charles River Laboratories International Inc., Contract manufacturing -- Health aspects, T cells -- Health aspects, DNA -- Health aspects, Cancer -- Care and treatment -- Genetic aspects, Genetic vectors -- Health aspects, Pharmaceutical industry -- Health aspects, Biotechnology industry, Health, Science and technology
Abstract

2024 JUL 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results